• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.前列腺病变在系列多参数磁共振成像上的自然史
Can Urol Assoc J. 2018 Aug;12(8):270-275. doi: 10.4859/cuaj.4859. Epub 2018 Apr 6.
2
Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.前列腺病变在系列多参数磁共振成像上的自然史
Can Urol Assoc J. 2018 Aug(12):8. doi: 10.5489/cuaj.4859. Epub 2018 Apr 6.
3
Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.经直肠超声引导下随机活检发现前列腺癌,尽管实时磁共振成像/超声融合引导下靶向活检结果为阴性:靶向活检失败的原因
BJU Int. 2016 Jul;118(1):35-43. doi: 10.1111/bju.13327. Epub 2015 Oct 20.
4
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.多参数磁共振成像(MRI)和 MRI-经直肠超声融合活检用于检测起始肿瘤:与根治性前列腺切除术标本的相关性。
Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.
5
Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.3特斯拉多参数磁共振成像及靶向活检在考虑进行主动监测的患者中改善风险分层的价值
BJU Int. 2017 Apr;119(4):535-542. doi: 10.1111/bju.13624. Epub 2016 Sep 3.
6
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.使用新型配准软件和多参数MRI PI-RADS评分对既往接受过前列腺活检的男性进行靶向MRI/TRUS融合引导活检:初步结果
World J Urol. 2015 Nov;33(11):1707-14. doi: 10.1007/s00345-015-1525-4. Epub 2015 Mar 14.
7
MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.多参数前列腺 MRI 发现前列腺影像报告和数据系统版本 2 类别 5 病变的 MRI-超声融合靶向活检为假阳性。
AJR Am J Roentgenol. 2018 May;210(5):W218-W225. doi: 10.2214/AJR.17.18680. Epub 2018 Feb 28.
8
Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: Real-life data from an Academic Center.基于多参数磁共振成像的 PIRADS-2 病变自然史:来自学术中心的真实数据。
Urol Oncol. 2025 Jan;43(1):65.e9-65.e15. doi: 10.1016/j.urolonc.2024.08.007. Epub 2024 Sep 10.
9
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)评分与指数病变和多灶性、临床显著前列腺癌的相关性。
Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.
10
Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.多参数 MRI 预测真实世界前列腺癌病理和肿瘤分期的准确性评估:一项多中心研究。
BJU Int. 2019 Aug;124(2):297-301. doi: 10.1111/bju.14696. Epub 2019 Feb 25.

引用本文的文献

1
The natural history of prostate cancer.前列腺癌的自然病史。
Can Urol Assoc J. 2025 Aug;19(8):275-281. doi: 10.5489/cuaj.9117.
2
Biparametric MRI in prostate cancer during active surveillance: is it safe?前列腺癌主动监测中的双参数 MRI:安全吗?
Eur Radiol. 2024 Oct;34(10):6217-6226. doi: 10.1007/s00330-024-10770-z. Epub 2024 Apr 24.
3
Stability of Multi-Parametric Prostate MRI Radiomic Features to Variations in Segmentation.多参数前列腺MRI影像组学特征对分割变化的稳定性
J Pers Med. 2023 Jul 22;13(7):1172. doi: 10.3390/jpm13071172.
4
A prospective study of cancer detection rates following early repeat imaging and biopsy of PI-RADS 4 and 5 regions of interest exhibiting no clinically significant prostate cancer on prior biopsy.一项前瞻性研究,针对先前活检未发现临床显著前列腺癌的PI-RADS 4和5类感兴趣区域进行早期重复成像和活检后的癌症检测率。
Can Urol Assoc J. 2022 Dec;16(12):418-422. doi: 10.5489/cuaj.7843.
5
Bridging the gap between prostate radiology and pathology through machine learning.通过机器学习弥合前列腺放射学与病理学之间的差距。
Med Phys. 2022 Aug;49(8):5160-5181. doi: 10.1002/mp.15777. Epub 2022 Jun 13.
6
Alternatives for MRI in Prostate Cancer Diagnostics-Review of Current Ultrasound-Based Techniques.前列腺癌诊断中MRI的替代方法——基于超声的当前技术综述
Cancers (Basel). 2022 Apr 7;14(8):1859. doi: 10.3390/cancers14081859.
7
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.基于磁共振成像的前列腺癌主动监测的 5 年结果:一项大型队列研究。
Eur Urol. 2020 Sep;78(3):443-451. doi: 10.1016/j.eururo.2020.03.035. Epub 2020 Apr 30.
8
Magnetic resonance imaging diagnosis of prostate cancer: promise and caution.前列腺癌的磁共振成像诊断:前景与警示
CMAJ. 2019 Oct 28;191(43):E1177-E1178. doi: 10.1503/cmaj.190568.
9
Multiparametric MRI for prostate cancer diagnosis: current status and future directions.多参数 MRI 用于前列腺癌诊断:现状与未来方向。
Nat Rev Urol. 2020 Jan;17(1):41-61. doi: 10.1038/s41585-019-0212-4. Epub 2019 Jul 17.
10
Early Second Round Targeted Biopsy of PI-RADS Score 3 or 4 in 256 Men With Persistent Suspicion of Prostate Cancer.对256名仍怀疑患有前列腺癌的男性进行PI-RADS 3或4分的早期第二轮靶向活检。
In Vivo. 2019 May-Jun;33(3):897-901. doi: 10.21873/invivo.11556.

本文引用的文献

1
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.多参数 MRI 和 TRUS 活检在前列腺癌(PROMIS)中的诊断准确性:一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
2
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.前列腺癌主动监测中的系列磁共振成像:增量价值
J Urol. 2016 May;195(5):1421-1427. doi: 10.1016/j.juro.2015.11.055. Epub 2015 Dec 7.
3
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.PI-RADS前列腺影像报告和数据系统:2015版,第2版
Eur Urol. 2016 Jan;69(1):16-40. doi: 10.1016/j.eururo.2015.08.052. Epub 2015 Oct 1.
4
The role of MRI in active surveillance for prostate cancer.磁共振成像(MRI)在前列腺癌主动监测中的作用。
Curr Urol Rep. 2015 Jun;16(6):42. doi: 10.1007/s11934-015-0507-9.
5
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.连续多参数磁共振成像在前列腺癌主动监测患者管理中的应用
Urol Oncol. 2015 May;33(5):202.e1-202.e7. doi: 10.1016/j.urolonc.2015.01.023. Epub 2015 Mar 6.
6
Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.多参数磁共振成像靶向活检用于检测既往活检结果为阴性的前列腺癌患者的前列腺癌。
Urol Oncol. 2015 Apr;33(4):165.e1-7. doi: 10.1016/j.urolonc.2015.01.004. Epub 2015 Feb 7.
7
Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer.多参数磁共振成像增强了对前列腺癌主动监测患者中显著肿瘤的检测。
Urology. 2015 Feb;85(2):423-8. doi: 10.1016/j.urology.2014.09.060.
8
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.多参数磁共振成像上可疑前列腺癌的小指数病变的自然史:间隔成像随访建议
Diagn Interv Radiol. 2014 Jul-Aug;20(4):293-8. doi: 10.5152/dir.2014.13319.
9
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.与系统性经直肠超声12针穿刺活检相比,磁共振成像/超声融合活检能显著提升前列腺癌的诊断水平。
Eur Urol. 2013 Nov;64(5):713-719. doi: 10.1016/j.eururo.2013.05.059. Epub 2013 Jun 12.
10
Systematic review of complications of prostate biopsy.前列腺活检并发症的系统评价。
Eur Urol. 2013 Dec;64(6):876-92. doi: 10.1016/j.eururo.2013.05.049. Epub 2013 Jun 4.

前列腺病变在系列多参数磁共振成像上的自然史

Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.

作者信息

Ghavimi Samrad, Abdi Hamidreza, Waterhouse Jennifer, Savdie Richard, Chang Silvia, Harris Alison, Machan Lindsay, Gleave Martin, So Alan I, Goldenberg Larry, Black Peter C

机构信息

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Department of Radiology, University of British Columbia, Vancouver, BC, Canada.

出版信息

Can Urol Assoc J. 2018 Aug;12(8):270-275. doi: 10.4859/cuaj.4859. Epub 2018 Apr 6.

DOI:10.4859/cuaj.4859
PMID:30139428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6114162/
Abstract

INTRODUCTION

The natural history of prostatic lesions identified on multiparametric magnetic resonance imaging (mpMRI) is largely unknown. We aimed to describe changes observed over time on serial MRI.

METHODS

All patients with ≥2 MRI studies between 2008 and 2015 at our institution were identified. MRI progression was defined as an increase in Prostate Imaging Reporting and Data System (PI-RADS; version 2) or size of existing lesions, or the appearance of a new lesion PIRADS ≥4. Patients on active surveillance (AS) were analyzed for correlation of MRI progression to biopsy reclassification.

RESULTS

A total of 83 patients (54 on AS and 29 for diagnostic purposes) underwent serial MRI, with a mean interval of 1.9 years between scans. At baseline, 115 lesions (66 index, 49 non-index) were identified. Index lesions were more likely than non-index lesions to increase in size ≥2 mm (36.2 vs. 7.3 %; p=0.002). Overall progression was more likely to be seen among the index cohort (34.8 vs. 7.6%; p<0.001). New lesions with PI-RADS ≥4 were seen on second imaging in 13 (16.5%) men, and became the index lesion in 29 cases (34.9%). Eighteen men on AS showed evidence of MRI progression (five with new lesions, 13 with progression of a previous lesion). Biopsy reclassification was present in three men (16.7%) with and seven men without MRI progression (19.4%).

CONCLUSIONS

Overall changes in size and PI-RADS scores of index lesions on MRI were small. New lesions were common, but usually did not alter management.

摘要

引言

多参数磁共振成像(mpMRI)所发现的前列腺病变的自然病程很大程度上尚不清楚。我们旨在描述在系列MRI上随时间观察到的变化。

方法

确定了2008年至2015年间在我们机构进行了≥2次MRI检查的所有患者。MRI进展定义为前列腺影像报告和数据系统(PI-RADS;第2版)增加或现有病变大小增加,或出现新的PI-RADS≥4的病变。对接受主动监测(AS)的患者分析MRI进展与活检重新分类的相关性。

结果

共有83例患者(54例接受AS,29例用于诊断)接受了系列MRI检查,扫描间隔的平均时间为1.9年。在基线时,共识别出115个病变(66个索引病变,49个非索引病变)。索引病变比非索引病变更有可能增大≥2mm(36.2%对7.3%;p=0.002)。总体进展在索引队列中更常见(34.8%对7.6%;p<0.001)。在第二次成像时,13例(16.5%)男性出现了PI-RADS≥4的新病变,其中29例(34.9%)成为索引病变。18例接受AS的男性显示出MRI进展的证据(5例有新病变,13例先前病变有进展)。3例有MRI进展的男性(16.7%)和7例无MRI进展的男性(19.4%)出现了活检重新分类。

结论

MRI上索引病变的大小和PI-RADS评分的总体变化较小。新病变很常见,但通常不会改变治疗方案。